Watanabe T, Sano M, Takashima S, et al. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer : National Surgical Adjuvant Study for Breast Cancer 01 Trial. J Clin Oncol 2009 ; 27 : 1368.
Hara F, Watanabe T, Shimozuma K, Ohashi Y. Efficacy, toxicity and quality of life in older patients with early-stage breast cancer treated with oral tegafur-uracil or classical CMF (cyclophosphamide, methotrexate, and fluorouracil): an exploratory analysis of National Surgical Adjuvant Study for Breast Cancer (N-SAS BC) 01 Trial [abstract] . Cancer Res 2012 ; 72 Suppl 24 : 198s.